Breztri Aerosol, Metered
Product Images NDC 0310-4616

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Breztri (NDC 0310-4616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide Chemical Structure (Budesonidechemstructure)

Chemical structure of budesonide, one of the active ingredients in BREZTRI aerosol, metered respiratory inhalation medication by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Carton (Container)

BREZTRI AEROSPHERE inhalation aerosol containing budesonide, glycopyrrolate, and formoterol fumarate at strengths of 160 mcg, 9 mcg, and 4.8 mcg per inhalation. The label shows the product is for oral inhalation only, includes directions to shake well before use, and provides 120 inhalations per container. Labeler is AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Figure 1 (Figure1)

A line graph depicting the adjusted mean change from baseline in trough FEV1 (L) over 52 weeks post-dose. It compares three treatment groups: BREZTRI AEROSPHERE 320/18/9.6 mcg, GFF MDI 18/9.6 mcg, and BFF MDI 320/9.6 mcg. The graph shows FEV1 improvements peaking early then gradually declining over time for each group.*

FDA Label Image

Formoterol Fumarate Chemical Structure (Formoterolfumaratechemstructure)

Chemical structure showing the molecular formula of formoterol fumarate dihydrate, one of the active ingredients in BREZTRI aerosol for inhalation by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Glycopyrrolate Chemical Structure (Glycopyrrolatechemstructure)

Chemical structure diagram showing the molecular structure of glycopyrrolate, one of the active ingredients in BREZTRI inhalation aerosol.*

FDA Label Image

Figure 1 (cartridge)

Illustration showing a side and top view of the BREZTRI metered-dose aerosol inhaler. The side view labels the cap, mouthpiece, actuator, and canister. The top view highlights the dose indicator with a display window, pointer, and a press here area for checking remaining doses.*

FDA Label Image

Figure 2a, 2b, 2c (dose indicators)

An instructional illustration depicting three circular dose counters labeled Figure 2a, 2b, and 2c, showing remaining puffs on an inhaler device. The counters display 120 puffs, 110 puffs, and 100 puffs respectively, indicated by shaded segments and numeric values, representing different levels of remaining doses in the inhaler.*

FDA Label Image

Figure 2d (dose indicator diaplay changes color)

Illustration of a circular dose counter dial for an aerosol medication inhaler, showing a numeric scale from 0 to 40 with an arrow indicator used to monitor remaining doses.*

FDA Label Image

Figure 3 (priming your inhaler)

An instructional illustration showing a hand holding a BREZTRI metered aerosol inhaler with the other hand removing the cap by pulling it straight off. This diagram demonstrates how to properly remove the inhaler cap before use.*

FDA Label Image

Figure 4 (press down)

An instructional diagram showing a person holding a metered dose inhaler, demonstrating shaking the inhaler up and down before use. This likely illustrates proper use of the BREZTRI aerosol inhaler for respiratory administration.*

FDA Label Image

Figure 5 (release a puff of medicine)

An instructional illustration depicting the proper use of a metered-dose inhaler. The image shows a hand holding the inhaler with an arrow indicating to press down on the canister to release the aerosol while a person’s profile demonstrates inhaling the medication through the mouthpiece.*

FDA Label Image

Figure 6 (remove the cap)

Instructional illustration showing a person removing the cap from an inhaler device with one hand while holding the inhaler with the other hand. The inhaler is likely an aerosol, metered dose used for respiratory inhalation.*

FDA Label Image

Figure 7 (shake inhaler)

An instructional illustration depicting a hand holding a metered-dose inhaler. The image shows arrows indicating the shaking motion of the inhaler before use, highlighting the steps to prepare the aerosol for inhalation.*

FDA Label Image

Figure 8 (breathe out)

An instructional illustration showing a person holding a metered dose inhaler and exhaling away from the inhaler mouthpiece. The diagram indicates proper technique for inhalation, with arrows depicting breath direction away from the device before use.*

FDA Label Image

Figure 9 (close your lips)

An instructional illustration showing a person holding and using a BREZTRI aerosol metered inhaler by positioning it near their mouth for respiratory inhalation.*

FDA Label Image

Figure 10 (breathe in deeply and slowly)

An instructional illustration showing the proper use of a metered dose inhaler. It depicts a person holding the inhaler to their mouth with arrows indicating the direction of inhalation for respiratory delivery.*

FDA Label Image

Figure 11 (hold your breath)

Illustration showing a side view of a person's face, likely demonstrating the correct positioning or usage technique for the BREZTRI aerosol metered inhalation product by AstraZeneca Pharmaceuticals LP.*

FDA Label Image

Figure 12 (breath out gently)

An instructional illustration showing a side profile of a person's face demonstrating exhalation or breathing out through the mouth, indicated by arrows extending outward. This figure is part of a usage guide for a respiratory inhalation aerosol device.*

FDA Label Image

Figure 13 (replace the cap)

An instructional illustration showing a person holding a BREZTRI metered aerosol inhaler, with one hand stabilizing the device and the other hand pressing down on the top to release a dose. This diagram demonstrates the proper technique for activating the inhaler.*

FDA Label Image

Figure 14 (good and bad air flow)

An instructional illustration showing proper and improper use of a metered dose inhaler. The top image depicts correct actuation with the inhaler held upright and medication being released. The bottom image shows incorrect use, with the inhaler tilted downward and medication leaking out the bottom.*

FDA Label Image

Figure 15 (take canister out)

An instructional line drawing showing a hand holding an inhaler device and inserting a medication canister into it. The illustration depicts the canister being pushed downward into the inhaler body, demonstrating the assembly step for use.*

FDA Label Image

Figure 16 (hold under running warm water)

An instructional illustration showing how to wash a metered aerosol inhaler device under running water. The illustration is split into two panels: the left panel shows a hand holding the inhaler under running water, and the right panel shows the hand rinsing the inhaler nozzle under the faucet.*

FDA Label Image

Figure 17 (leave air-dry over night)

Figure showing a nighttime window with a crescent moon, accompanied by an assembly of inhaler device components including a medication canister, inhaler body, and mouthpiece cap, suggesting instruction or depiction related to respiratory inhalation use.*

FDA Label Image

Figure 18 (when dry gently press canister into actuator)

Illustration showing the correct use of a BREZTRI metered-dose inhaler. The image depicts two hands holding the inhaler, with an arrow indicating downward pressing, likely demonstrating how to activate or use the aerosol inhalation device.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.